Halozyme Therapeutics Earnings Surprises image   This HALO earnings surprises page last updated 3/12/2024
Halozyme Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 0.83 0.82 -0.01 (-1%)
Q3 2023 0.73 0.75 +0.02 (+3%)
Q2 2023 0.63 0.74 +0.11 (+17%)
Q1 2023 0.48 0.47 -0.01 (-2%)
Q4 2022 0.47 0.48 +0.01 (+2%)
Q3 2022 0.51 0.74 +0.23 (+45%)
Q2 2022 0.50 0.53 +0.03 (+6%)
Q1 2022 0.49 0.47 -0.02 (-4%)
Q4 2021 0.41 0.42 +0.01 (+2%)
Q3 2021 0.42 0.55 +0.13 (+31%)
Q2 2021 0.40 0.66 +0.26 (+65%)
Q1 2021 0.32 0.37 +0.05 (+16%)
Q4 2020 0.53 0.50 -0.03 (-6%)
Q3 2020 0.20 0.25 +0.05 (+25%)
Q2 2020 0.25 0.19 -0.06 (-24%)
Q1 2020 -0.02 -0.04 -0.02 (+100%)
Q4 2019 -0.15 -0.24 -0.09 (+60%)
Q3 2019 -0.12 -0.17 -0.05 (+42%)
Q2 2019 -0.14 -0.10 +0.04 (-29%)
Q4 2018 -0.03 -0.01 +0.02 (-67%)
Q3 2018 -0.23 -0.19 +0.04 (-17%)
Q2 2018 -0.22 -0.16 +0.06 (-27%)
Q1 2018 -0.22 -0.19 +0.03 (-14%)
Q3 2017 0.06 0.02 -0.04 (-67%)
Q2 2017 -0.24 -0.23 +0.01 (-4%)
Q1 2017 -0.25 -0.26 -0.01 (+4%)
Q4 2016 -0.28 -0.21 +0.07 (-25%)
Q3 2016 -0.27 -0.23 +0.04 (-15%)
Q2 2016 -0.27 -0.21 +0.06 (-22%)
Q1 2016 -0.20 -0.16 +0.04 (-20%)
Q4 2015 -0.08 0.03 +0.11 (-138%)
Q3 2015 -0.16 -0.19 -0.03 (+19%)
Q2 2015 -0.09 0.02 +0.11 (-122%)
Q1 2015 -0.13 -0.12 +0.01 (-8%)
Q4 2014 -0.07 -0.04 +0.03 (-43%)
Q3 2014 -0.14 -0.16 -0.02 (+14%)
Q2 2014 -0.14 -0.13 +0.01 (-7%)
Q1 2014 -0.14 -0.22 -0.08 (+57%)
Q4 2013 -0.17 -0.19 -0.02 (+12%)
Q3 2013 -0.15 -0.17 -0.02 (+13%)
Q2 2013 -0.13 -0.20 -0.07 (+54%)
Q1 2013 -0.15 -0.17 -0.02 (+13%)
Q3 2012 -0.14 -0.18 -0.04 (+29%)
Q2 2012 -0.15 -13.00 -12.85 (+8567%)
Halozyme Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 233.19M 230.04M -3.15M (-1%)
Q3 2023 222.63M 216.03M -6.60M (-3%)
Q2 2023 199.32M 221.04M +21.72M (+11%)
Q1 2023 175.51M 162.14M -13.37M (-8%)
Q4 2022 192.05M 181.50M -10.55M (-5%)
Q3 2022 191.10M 208.98M +17.88M (+9%)
Q2 2022 138.78M 152.37M +13.59M (+10%)
Q1 2022 128.25M 117.28M -10.97M (-9%)
Q4 2021 100.32M 102.00M +1.68M (+2%)
Q3 2021 101.94M 115.83M +13.89M (+14%)
Q2 2021 103.16M 136.46M +33.30M (+32%)
Q1 2021 84.88M 89.02M +4.14M (+5%)
Q4 2020 120.16M 121.70M +1.54M (+1%)
Q3 2020 60.91M 65.32M +4.41M (+7%)
Q2 2020 66.68M 55.22M -11.46M (-17%)
Q1 2020 42.96M 25.35M -17.61M (-41%)
Q4 2019 56.93M 53.66M -3.27M (-6%)
Q3 2019 54.81M 46.23M -8.58M (-16%)
Q2 2019 42.76M 39.15M -3.61M (-8%)
Q4 2018 59.94M 60.23M +292000 (0%)
Q3 2018 30.42M 25.56M -4.86M (-16%)
Q2 2018 30.09M 35.20M +5.11M (+17%)
Q1 2018 31.43M 30.87M -0.56M (-2%)
Q3 2017 84.70M 63.73M -20.97M (-25%)
Q2 2017 31.56M 33.75M +2.19M (+7%)
Q1 2017 30.85M 29.57M -1.28M (-4%)
Q4 2016 38.37M 39.00M +633000 (+2%)
Q3 2016 34.27M 31.85M -2.42M (-7%)
Q2 2016 29.94M 33.34M +3.40M (+11%)
Q1 2016 29.65M 42.50M +12.85M (+43%)
Q4 2015 42.06M 52.23M +10.17M (+24%)
Q3 2015 24.01M 20.78M -3.23M (-13%)
Q2 2015 24.84M 43.38M +18.54M (+75%)
Q1 2015 19.40M 18.67M -0.73M (-4%)
Q4 2014 25.59M 30.38M +4.79M (+19%)
Q3 2014 16.45M 14.60M -1.85M (-11%)
Q2 2014 13.71M 14.61M +896000 (+7%)
Q1 2014 13.37M 11.97M -1.40M (-10%)
Q4 2013 16.39M 12.50M -3.89M (-24%)
Q3 2013 14.62M 16.01M +1.39M (+10%)
Q2 2013 11.28M 14.50M +3.22M (+29%)
Q1 2013 7.05M 11.80M +4.75M (+67%)
Q3 2012 6.09M 5.30M -0.79M (-13%)
Q2 2012 5.22M 7.76M +2.54M (+49%)
Quotes delayed 20 minutes

Email EnvelopeFree HALO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Archer-Daniels Midland (ADM): 3/12/2024 7:00 AM
Tupperware Brands (TUP): 3/12/2024 7:00 AM
BioXcel Therapeutics (BTAI): 3/12/2024 7:00 AM
Priority Tech Holdings (PRTH): 3/12/2024 7:00 AM
Chicago Atlantic Real (REFI): 3/12/2024 7:00 AM
Hagerty (HGTY): 3/12/2024 7:00 AM
Bioventus (BVS): 3/12/2024 7:00 AM
PowerFleet (PWFL): 3/12/2024 7:00 AM
Lifetime Brands (LCUT): 3/12/2024 7:00 AM
Kohl's (KSS): 3/12/2024 7:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Energy Fuels (UUUU): 3/11/2024 6:00 PM
NN (NNBR): 3/11/2024 5:05 PM
Smart Sand (SND): 3/11/2024 5:00 PM
Fuel Tech (FTEK): 3/11/2024 After close
Casey's General Stores (CASY): 3/11/2024 After close
NET Power (NPWR): 3/11/2024 After close
PLAYSTUDIOS (MYPS): 3/11/2024 After close
NGM Biopharmaceuticals (NGM): 3/11/2024 After close
Heritage Insurance Hldgs (HRTG): 3/11/2024 After close
Olema Pharmaceuticals (OLMA): 3/11/2024 After close

More from the Earnings History archive
Halozyme Therapeutics (HALO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

HARP Historical Earnings
HBIO Historical Earnings
HCA Historical Earnings
HCWB Historical Earnings
HEPA Historical Earnings
HGEN Historical Earnings
HJLI Historical Earnings
HLTH Historical Earnings
HLVX Historical Earnings
HNGR Historical Earnings
On this page we presented the HALO earnings surprises information for Halozyme Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on HALO (or any other given stock) can benefit from researching all of the Halozyme Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Halozyme Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about HALO's next earnings report. In your continued research on Halozyme Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for HALO. Thanks for visiting, and the next time you need to research HALO earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Becton, Dickinson MACD, Funds Holding DFSE, CYM Historical Stock Prices.

 

Halozyme Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.